|Articles|August 15, 2014
- BioPharm International-08-15-2014
- Volume 2014 eBook
- Issue 2
Testing the Quality, Safety, and Efficacy of Insulin Biosimilars
Development and validation of two pivotal assays for in-vitro comparability testing of insulin biosimilars.
Advertisement
Development and validation of two pivotal assays for in-vitro comparability testing of insulin biosimilars.
from BioPharm International’s 2014 Analytical and Bioanalytical eBook.
Articles in this issue
over 11 years ago
Keys to Successful Method Transferover 11 years ago
The Challenge of Finding the Unknownover 11 years ago
Using the Purity Quotient Difference to Assess Protein Purificationover 11 years ago
Standardizing Data ManagementNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics
2
FAQ: What Precision Analytics Have Done to Advance Next-Gen Biologics
3
EMA Director Highlights Agency Achievements in 2025
4
Ask the Expert: Training for a Skilled Workforce
5